This article is more than 5 years old. Information may no longer be current.

Collaborative retinoblastoma center opens, offers gene therapy

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

HOUSTON — Doctors and researchers from four Texas medical institutions have joined to form the Retinoblastoma Center of Houston, according to a press release from Methodist Hospital.

The center includes experts from Texas Children's Cancer Center, Children's Cancer Hospital at The University of Texas M.D. Anderson Cancer Center, Methodist Hospital and Baylor College of Medicine. The center is the first in the U.S. to use gene therapy and proton therapy in an attempt to treat and cure retinoblastoma. Genetic testing will also take place at the center to identify potential hereditary markers.

Patients of the Retinoblastoma Center of Houston will be seen at Texas Children's Cancer Center, Children's Cancer Hospital at The University of Texas M.D. Anderson Cancer Center and Methodist Hospital. The Methodist Hospital Research Institute will house the Center's tumor bank and conduct tissue diagnostic analysis.